Related Experiment Video
Updated: Dec 4, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate
Andrew B Das1, Carlos C Smith-Díaz2, Margreet C M Vissers2
1Department of Pathology and Biomedical Science, University of Otago, Christchurch. andrew.das@otago.ac.nz.
Epigenetic drugs show promise for acute myeloid leukemia but face challenges like varied patient response and resistance. Ascorbate may offer a new therapeutic strategy by targeting epigenetic plasticity and restoring enzyme function.
Area of Science:
- Epigenetics
- Cancer Biology
- Pharmacology
More Related Videos
13:47Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
11:53An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...